$RNN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ocuphire Pharma, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Ocuphire Pharma, Inc.. Get notifications about new insider transactions in Ocuphire Pharma, Inc. for free.

Page: 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 09 2021	RNN	Ocuphire Pharma, I ...	Pepose Jay		Option Exercise	A	5.74	40,000	229,600	40,000
Jun 09 2021	RNN	Ocuphire Pharma, I ...	Rodgers Richard J		Option Exercise	A	5.74	20,000	114,800	20,000
Jun 09 2021	RNN	Ocuphire Pharma, I ...	MANUSO JAMES S J		Option Exercise	A	5.74	20,000	114,800	20,000
Apr 05 2021	RNN	Ocuphire Pharma, I ...	Benton Susan		Grant	A	0.00	1,893	0	1,893	0 to 1.9 K
Apr 05 2021	RNN	Ocuphire Pharma, I ...	Rodgers Richard J		Grant	A	0.00	2,581	0	26,221	23.6 K to 26.2 K (+10.92 %)
Nov 25 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Option Exercise	P	0.00	315	0	315
Nov 25 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Option Exercise	P	4.48	2,679	12,001	2,679
Nov 25 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Buy	P	0.00	1,771	0	487,029	485.3 K to 487 K (+0.36 %)
Nov 25 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Option Exercise	P	0.00	315	0	315
Nov 25 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Option Exercise	P	4.48	2,679	12,001	2,679
Nov 25 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Buy	P	0.00	1,771	0	487,029	485.3 K to 487 K (+0.36 %)
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Option Exercise	P	0.00	1,574	0	1,574
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Option Exercise	P	4.48	13,394	59,998	13,394
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Buy	P	0.00	8,865	0	44,665	35.8 K to 44.7 K (+24.76 %)
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Option Exercise	P	0.00	1,574	0	1,574
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Option Exercise	P	4.48	13,394	59,998	13,394
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	P	0.00	2,046	0	2,046
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Buy	P	0.00	8,865	0	44,665	35.8 K to 44.7 K (+24.76 %)
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	P	4.48	17,413	78,002	17,413
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Buy	P	0.00	11,524	0	800,044	788.5 K to 800 K (+1.46 %)
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	P	0.00	2,046	0	2,046
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	P	4.48	17,413	78,002	17,413
Nov 25 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Buy	P	0.00	11,524	0	800,044	788.5 K to 800 K (+1.46 %)
Nov 16 2020	RNN	Ocuphire Pharma, I ...	Zaremba Rabourn Amy	VP of Finance	Option Exercise	A	4.05	75,000	303,750	75,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean		Option Exercise	A	4.05	5,000	20,250	5,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	Rodgers Richard J		Option Exercise	A	4.05	50,000	202,500	50,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	A	4.05	130,000	526,500	130,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	MANUSO JAMES S J		Option Exercise	A	4.05	5,000	20,250	5,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	Gallagher Cam		Option Exercise	A	4.05	5,000	20,250	5,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	Hoffmann Bernhard	VP of Corp. Dev. & ...	Option Exercise	A	4.05	20,000	81,000	20,000
Nov 13 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Option Exercise	A	4.05	7,500	30,375	7,500
Nov 13 2020	RNN	Ocuphire Pharma, I ...	MEYER ALAN R		Option Exercise	A	4.05	7,500	30,375	7,500
Nov 09 2020	RNN	Ocuphire Pharma, I ...	MANUSO JAMES S J	Director	Option Exercise	A	1.21	52,825	63,918	52,825
Nov 09 2020	RNN	Ocuphire Pharma, I ...	MANUSO JAMES S J	Director	Option Exercise	A	0.90	35,663	32,097	35,663
Nov 09 2020	RNN	Ocuphire Pharma, I ...	MANUSO JAMES S J	Director	Grant	A	0.00	10,136	0	10,136	0 to 10.1 K
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Gallagher Cam	Director	Option Exercise	A	1.21	52,825	63,918	52,825
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Gallagher Cam	Director	Option Exercise	A	0.90	35,663	32,097	35,663
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Gallagher Cam	Director	Grant	A	0.00	14,489	0	14,489	0 to 14.5 K
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean	Director	Option Exercise	A	1.21	52,825	63,918	52,825
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean	Director	Option Exercise	A	0.90	35,663	32,097	35,663
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Ainsworth Sean	Director	Grant	A	0.00	35,800	0	35,800	0 to 35.8 K
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Hoffmann Bernhard	VP of Corp. Dev. an ...	Option Exercise	A	1.65	4,226	6,973	4,226
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Hoffmann Bernhard	VP of Corp. Dev. an ...	Option Exercise	A	1.21	30,110	36,433	30,110
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Hoffmann Bernhard	VP of Corp. Dev. an ...	Option Exercise	A	0.90	42,867	38,580	42,867
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Hoffmann Bernhard	VP of Corp. Dev. an ...	Grant	A	0.00	100,120	0	100,120	0 to 100.1 K
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	A	1.21	158,475	191,755	158,475
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Option Exercise	A	0.90	178,284	160,456	178,284
Nov 09 2020	RNN	Ocuphire Pharma, I ...	Sooch Mina	President and CEO	Grant	A	0.00	788,520	0	788,520	0 to 788.5 K
Jun 07 2019	RNN	REXAHN PHARMACEUTI ...	Cheong Kwang Soo		Option Exercise	A	5.23	3,537	18,499	3,537
Jun 07 2019	RNN	REXAHN PHARMACEUTI ...	Rodgers Richard J		Option Exercise	A	5.23	3,537	18,499	3,537
Jun 07 2019	RNN	REXAHN PHARMACEUTI ...	Sullivan Lara		Option Exercise	A	5.23	3,537	18,499	3,537
Jun 07 2019	RNN	REXAHN PHARMACEUTI ...	Brandt Peter C.		Option Exercise	A	5.23	3,537	18,499	3,537
Jun 07 2019	RNN	REXAHN PHARMACEUTI ...	Price Ben Gil		Option Exercise	A	5.23	3,537	18,499	3,537
Jun 07 2019	RNN	REXAHN PHARMACEUTI ...	Beever Charles		Option Exercise	A	5.23	3,537	18,499	3,537
Mar 01 2019	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	M	0.00	1,625	0	3,250
Mar 01 2019	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Buy	M	0.00	1,625	0	23,250	21.6 K to 23.3 K (+7.51 %)
Mar 01 2019	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	M	0.00	2,375	0	4,750
Mar 01 2019	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Buy	M	0.00	2,375	0	4,750	2.4 K to 4.8 K (+100.00 %)
Mar 01 2019	RNN	REXAHN PHARMACEUTI ...	Sullivan Lara		Option Exercise	A	0.53	84,968	45,033	84,968
Jan 31 2019	RNN	REXAHN PHARMACEUTI ...	Price Ben Gil		Buy	P	0.61	15,000	9,141	15,000	0 to 15 K
Jan 31 2019	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Buy	P	0.65	20,000	12,960	21,625	1.6 K to 21.6 K (+1,230.77 %)
Jan 30 2019	RNN	REXAHN PHARMACEUTI ...	Swirsky Douglas J	President and CEO	Buy	P	0.63	50,000	31,720	50,000	0 to 50 K
Jan 25 2019	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	A	0.62	130,000	80,730	130,000
Jan 25 2019	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	0.62	100,000	62,100	100,000
Dec 03 2018	RNN	REXAHN PHARMACEUTI ...	Price Ben Gil		Option Exercise	A	1.10	112,878	124,166	112,878
Nov 16 2018	RNN	REXAHN PHARMACEUTI ...	Swirsky Douglas J	President and CEO	Option Exercise	A	1.09	500,000	545,000	500,000
Jun 29 2018	RNN	REXAHN PHARMACEUTI ...	Beever Charles		Option Exercise	A	1.46	39,742	58,023	39,742
Jun 29 2018	RNN	REXAHN PHARMACEUTI ...	Brandt Peter C.		Option Exercise	A	1.46	39,742	58,023	39,742
Jun 29 2018	RNN	REXAHN PHARMACEUTI ...	Rodgers Richard J		Option Exercise	A	1.46	39,742	58,023	39,742
Jun 29 2018	RNN	REXAHN PHARMACEUTI ...	Cheong Kwang Soo		Option Exercise	A	1.46	39,742	58,023	39,742
Mar 09 2018	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	1.78	200,000	356,000	200,000
Mar 02 2018	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	M	0.00	1,625	0	4,875
Mar 02 2018	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	M	0.00	1,625	0	4,875
Mar 02 2018	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Buy	M	0.00	1,625	0	1,625	0 to 1.6 K
Mar 02 2018	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Buy	M	0.00	1,625	0	1,625	0 to 1.6 K
Mar 02 2018	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	M	0.00	6,250	0	18,750
Mar 02 2018	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Buy	M	0.00	6,250	0	22,250	16 K to 22.3 K (+39.06 %)
Jan 30 2018	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	2.29	112,271	257,101	112,271
Jan 30 2018	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	A	2.29	42,101	96,411	42,101
Jan 30 2018	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	2.29	45,443	104,064	45,443
Jan 04 2018	RNN	REXAHN PHARMACEUTI ...	Swirsky Douglas J	President and CFO	Option Exercise	A	2.10	250,000	525,000	250,000
Aug 16 2017	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Grant	A	1.99	10,000	19,872	16,000	6 K to 16 K (+166.67 %)
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	CARTHY MARK		Option Exercise	A	0.62	110,000	67,980	110,000
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Cheong Kwang Soo		Option Exercise	A	0.62	110,000	67,980	110,000
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho		Option Exercise	M	0.31	250,000	77,500	0
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho		Sell	S	0.70	250,000	175,375	6,010,000	6.3 M to 6 M (-3.99 %)
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho		Buy	M	0.31	250,000	77,500	6,260,000	6 M to 6.3 M (+4.16 %)
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Rodgers Richard J		Option Exercise	A	0.62	110,000	67,980	110,000
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Brandt Peter C.		Option Exercise	A	0.62	110,000	67,980	110,000
Apr 12 2017	RNN	REXAHN PHARMACEUTI ...	Beever Charles		Option Exercise	A	0.62	110,000	67,980	110,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	A	0.00	63,000	0	63,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	A	0.18	300,000	55,200	300,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	0.00	250,000	0	250,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	0.18	1,175,000	216,200	1,175,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	0.00	95,000	0	95,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	0.18	450,000	82,800	450,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	A	0.00	65,000	0	65,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	A	0.18	315,000	57,960	315,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho		Option Exercise	A	0.00	70,000	0	70,000
Jan 24 2017	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho		Option Exercise	A	0.18	330,000	60,720	330,000
Jul 08 2016	RNN	REXAHN PHARMACEUTI ...	Nolan Lisa	Chief Business Offi ...	Option Exercise	A	0.26	1,200,000	312,000	1,200,000
Jun 10 2016	RNN	REXAHN PHARMACEUTI ...	Rodgers Richard J	Director	Option Exercise	A	0.28	225,000	63,000	225,000
Jun 10 2016	RNN	REXAHN PHARMACEUTI ...	CARTHY MARK	Director	Option Exercise	A	0.28	225,000	63,000	225,000
Jun 10 2016	RNN	REXAHN PHARMACEUTI ...	Brandt Peter C.	Director	Option Exercise	A	0.28	225,000	63,000	225,000
Jun 10 2016	RNN	REXAHN PHARMACEUTI ...	Beever Charles	Director	Option Exercise	A	0.28	225,000	63,000	225,000
Jun 10 2016	RNN	REXAHN PHARMACEUTI ...	Cheong Kwang Soo	Director	Option Exercise	A	0.28	225,000	63,000	225,000
Mar 21 2016	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Grant	A	0.32	60,000	19,386	60,000	0 to 60 K
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	0.35	500,000	175,000	500,000
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	0.35	98,734	34,557	98,734
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	A	0.35	100,000	35,000	100,000
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	A	0.35	98,853	34,599	98,853
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	0.35	1,000,000	350,000	1,000,000
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	0.35	411,689	144,091	411,689
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	A	0.35	200,000	70,000	200,000
Feb 01 2016	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	A	0.35	214,461	75,061	214,461
Sep 18 2015	RNN	REXAHN PHARMACEUTI ...	Rodgers Richard J	Director	Option Exercise	A	0.54	90,000	48,600	90,000
Sep 18 2015	RNN	REXAHN PHARMACEUTI ...	Cheong Kwang Soo	Director	Option Exercise	A	0.54	90,000	48,600	90,000
Sep 18 2015	RNN	REXAHN PHARMACEUTI ...	CARTHY MARK	Director	Option Exercise	A	0.54	90,000	48,600	90,000
Sep 18 2015	RNN	REXAHN PHARMACEUTI ...	Brandt Peter C.	Director	Option Exercise	A	0.54	90,000	48,600	90,000
Sep 18 2015	RNN	REXAHN PHARMACEUTI ...	Beever Charles	Director	Option Exercise	A	0.54	90,000	48,600	90,000
Feb 04 2015	RNN	REXAHN PHARMACEUTI ...	Benaim Ely	Chief Medical Offic ...	Option Exercise	A	0.71	1,200,000	852,000	1,200,000
Jan 27 2015	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	0.71	1,100,000	781,000	1,100,000
Jan 27 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	A	0.71	333,332	236,666	333,332
Jan 27 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	A	0.71	333,332	236,666	333,332
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	M	0.80	49,800	39,840	182,728
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	M	0.80	188,690	150,952	232,528
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Option Exercise	M	0.80	78,782	63,026	421,218
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Sell	S	0.91	49,800	45,492	505,000	554.8 K to 505 K (-8.98 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Buy	M	0.80	49,800	39,840	554,800	505 K to 554.8 K (+9.86 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Sell	S	0.92	188,690	172,708	505,000	693.7 K to 505 K (-27.20 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Buy	M	0.80	188,690	150,952	693,690	505 K to 693.7 K (+37.36 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Sell	S	0.90	78,782	70,935	505,000	583.8 K to 505 K (-13.50 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Jeong Tae Heum	Chief Financial Off ...	Buy	M	0.80	78,782	63,026	583,782	505 K to 583.8 K (+15.60 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	M	0.80	48,444	38,755	549,151
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	M	0.80	186,212	148,970	597,595
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	M	0.80	80,000	64,000	783,807
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Sell	S	0.91	48,444	44,263	6,010,000	6.1 M to 6 M (-0.80 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Buy	M	0.80	48,444	38,755	6,058,444	6 M to 6.1 M (+0.81 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Sell	S	0.92	186,212	170,477	6,010,000	6.2 M to 6 M (-3.01 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Buy	M	0.80	186,212	148,970	6,196,212	6 M to 6.2 M (+3.10 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Sell	S	0.90	80,000	72,032	6,010,000	6.1 M to 6 M (-1.31 %)
Jan 12 2015	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Buy	M	0.80	80,000	64,000	6,090,000	6 M to 6.1 M (+1.33 %)
Dec 22 2014	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Gift	G	0.00	803,924	0	6,010,000	6.8 M to 6 M (-11.80 %)
Dec 03 2014	RNN	REXAHN PHARMACEUTI ...	Rodgers Richard J	Director	Option Exercise	A	0.68	30,000	20,400	30,000
Sep 05 2014	RNN	REXAHN PHARMACEUTI ...	Suzdak Peter David	Chief Executive Off ...	Option Exercise	A	0.83	1,000,000	830,000	1,000,000
Jun 16 2014	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Option Exercise	M	0.80	136,193	108,954	863,807
Jun 16 2014	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Sell	S	0.99	136,193	134,436	6,813,924	7 M to 6.8 M (-1.96 %)
Jun 16 2014	RNN	REXAHN PHARMACEUTI ...	Ahn Chang Ho	Director	Buy	M	0.80	136,193	108,954	6,950,117	6.8 M to 7 M (+2.00 %)
Jun 11 2014	RNN	REXAHN PHARMACEUTI ...	McIntosh David M	Director	Option Exercise	A	0.90	60,000	54,000	60,000
Jun 11 2014	RNN	REXAHN PHARMACEUTI ...	Hwang Si Moon	Director	Option Exercise	A	0.90	60,000	54,000	60,000

Page: 1 2 3 next >